Autism is a developmental disorder that affects the brain's normal development of social and communication skills. It is characterized by difficulties in social interaction, verbal and nonverbal communication, and repetitive behaviors. Autism spectrum disorder (ASD) is a general term for several conditions that have these features. The Centers for Disease Control and Prevention (CDC) estimates that 1 in 59 children has been identified with ASD. The global autism disorder treatment market was valued at USD 3,890 million in 2018 and is projected to reach USD 7,907 million by 2030, growing at a CAGR of 10.2% from 2019 to 2030. The market growth can be attributed to the increasing prevalence of autism spectrum disorders among children as well as the rising awareness about autism among parents which leads them to seek treatment for their child with ASD symptoms early on in life. The global autism disorder treatment market can be segmented on the basis of type into lo-functioning autism, high-functioning autism, Autism Disorder Treatment Market Treatment Market Treatment Market Treatment Market Autism Disorder Treatmenetal Disorders Treatmenetal Disorders Treatmenetal Disorders Treatmenetal Disorders Treatmenetal Disorders Autism Disorder Treatment Market Therapy (ABA), Speech Therapy (ST), Occupational Therapy (OT), Physical Therapy (PT). On the basis of application it can be segmented into 14?, 125?, 240?, Over 40? On the basis of region it can be segmented into North America, Latin America Europe Asia Pacific Middle East & Africa. -Autism is a lifelong condition, so the market will continue to grow as more people are diagnosed and need treatment. -There is a growing awareness of autism in society, which means that there will be an increase in demand for treatments. -The cost of treatment has decreased over time, which means that more people can afford it and the market will continue to grow as a result.
Industry Growth Insights published a new data on “Autism Disorder and Treatment Market”. The research report is titled “Autism Disorder and Treatment Market research by Types (Low-Functioning Autism, High-Functioning Autism, Autism Disorder and Treatmen), By Applications (1-14?, 15-25?, 26-40?, Over 40?), By Players/Companies Otsuka, AstraZeneca, Pfizer, AbbVie, Johnson & Johnson Services, GlaxoSmithKline, Roche, Eli Lilly, Abbott, Novartis, Intra-Cellular Therapies, Coronis Neurosciences, Sun Pharmaceutical, Autism Disorder and Treatmen”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Autism Disorder and Treatment Market Research Report
By Type
Low-Functioning Autism, High-Functioning Autism, Autism Disorder and Treatmen
By Application
1-14?, 15-25?, 26-40?, Over 40?
By Companies
Otsuka, AstraZeneca, Pfizer, AbbVie, Johnson & Johnson Services, GlaxoSmithKline, Roche, Eli Lilly, Abbott, Novartis, Intra-Cellular Therapies, Coronis Neurosciences, Sun Pharmaceutical, Autism Disorder and Treatmen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Autism Disorder and Treatment Market Report Segments:
The global Autism Disorder and Treatment market is segmented on the basis of:
Types
Low-Functioning Autism, High-Functioning Autism, Autism Disorder and Treatmen
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
1-14?, 15-25?, 26-40?, Over 40?
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Otsuka
- AstraZeneca
- Pfizer
- AbbVie
- Johnson & Johnson Services
- GlaxoSmithKline
- Roche
- Eli Lilly
- Abbott
- Novartis
- Intra-Cellular Therapies
- Coronis Neurosciences
- Sun Pharmaceutical
- Autism Disorder and Treatmen
Highlights of The Autism Disorder and Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Low-Functioning Autism
- High-Functioning Autism
- Autism Disorder and Treatmen
- By Application:
- 1-14?
- 15-25?
- 26-40?
- Over 40?
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Autism Disorder and Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Autism disorder is a developmental disorder that affects communication and social interaction. It is also known as Asperger's syndrome. Treatment typically includes therapy, medication, and special education services.
Some of the key players operating in the autism disorder and treatment market are Otsuka, AstraZeneca, Pfizer, AbbVie, Johnson & Johnson Services, GlaxoSmithKline, Roche, Eli Lilly, Abbott, Novartis, Intra-Cellular Therapies, Coronis Neurosciences, Sun Pharmaceutical, Autism Disorder and Treatmen.
The autism disorder and treatment market is expected to grow at a compound annual growth rate of 10.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Autism Disorder and Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Autism Disorder and Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Autism Disorder and Treatment Market - Supply Chain
4.5. Global Autism Disorder and Treatment Market Forecast
4.5.1. Autism Disorder and Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Autism Disorder and Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Autism Disorder and Treatment Market Absolute $ Opportunity
5. Global Autism Disorder and Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Autism Disorder and Treatment Market Size and Volume Forecast by Type
5.3.1. Low-Functioning Autism
5.3.2. High-Functioning Autism
5.3.3. Autism Disorder and Treatmen
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Autism Disorder and Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Autism Disorder and Treatment Market Size and Volume Forecast by Application
6.3.1. 1-14?
6.3.2. 15-25?
6.3.3. 26-40?
6.3.4. Over 40?
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Autism Disorder and Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Autism Disorder and Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Autism Disorder and Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Autism Disorder and Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Autism Disorder and Treatment Demand Share Forecast, 2019-2026
9. North America Autism Disorder and Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Autism Disorder and Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Autism Disorder and Treatment Market Size and Volume Forecast by Application
9.4.1. 1-14?
9.4.2. 15-25?
9.4.3. 26-40?
9.4.4. Over 40?
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Autism Disorder and Treatment Market Size and Volume Forecast by Type
9.7.1. Low-Functioning Autism
9.7.2. High-Functioning Autism
9.7.3. Autism Disorder and Treatmen
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Autism Disorder and Treatment Demand Share Forecast, 2019-2026
10. Latin America Autism Disorder and Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Autism Disorder and Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Autism Disorder and Treatment Market Size and Volume Forecast by Application
10.4.1. 1-14?
10.4.2. 15-25?
10.4.3. 26-40?
10.4.4. Over 40?
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Autism Disorder and Treatment Market Size and Volume Forecast by Type
10.7.1. Low-Functioning Autism
10.7.2. High-Functioning Autism
10.7.3. Autism Disorder and Treatmen
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Autism Disorder and Treatment Demand Share Forecast, 2019-2026
11. Europe Autism Disorder and Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Autism Disorder and Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Autism Disorder and Treatment Market Size and Volume Forecast by Application
11.4.1. 1-14?
11.4.2. 15-25?
11.4.3. 26-40?
11.4.4. Over 40?
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Autism Disorder and Treatment Market Size and Volume Forecast by Type
11.7.1. Low-Functioning Autism
11.7.2. High-Functioning Autism
11.7.3. Autism Disoder and Treatmen
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Autism Disorder and Treatment Demand Share, 2019-2026
12. Asia Pacific Autism Disorder and Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Autism Disorder and Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Autism Disorder and Treatment Market Size and Volume Forecast by Application
12.4.1. 1-14?
12.4.2. 15-25?
12.4.3. 26-40?
12.4.4. Over 40?
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Autism Disorder and Treatment Market Size and Volume Forecast by Type
12.7.1. Low-Functioning Autism
12.7.2. High-Functioning Autism
12.7.3. Autism Disorder and Treatmen
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Autism Disorder and Treatment Demand Share, 2019-2026
13. Middle East & Africa Autism Disorder and Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Autism Disorder and Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Autism Disorder and Treatment Market Size and Volume Forecast by Application
13.4.1. 1-14?
13.4.2. 15-25?
13.4.3. 26-40?
13.4.4. Over 40?
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Autism Disorder and Treatment Market Size and Volume Forecast by Type
13.7.1. Low-Functioning Autism
13.7.2. High-Functioning Autism
13.7.3. Autism Disorder and Treatmen
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Autism Disorder and Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Autism Disorder and Treatment Market: Market Share Analysis
14.2. Autism Disorder and Treatment Distributors and Customers
14.3. Autism Disorder and Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Otsuka
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. AstraZeneca
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pfizer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. AbbVie
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Johnson & Johnson Services
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. GlaxoSmithKline
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Roche
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Eli Lilly
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Abbott
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Novartis
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Intra-Cellular Therapies
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Coronis Neurosciences
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Sun Pharmaceutical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Autism Disorder and Treatmen
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook